Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Martin Bjerregård, Pedersen"'
Autor:
Thomas Relander, Martin Bjerregård Pedersen, Fredrik Ellin, Grete Fossum Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Holte, Anders Österborg, Peter De Nully Brown, Outi Kuittinen, Martin Erlanson, Bjorn Ostenstad, Unn-Merete Fagerli, Jan Delabie, Christer Sundström, Birgitta Sander, Stephen Hamilton-Dutoit, Mats Ehinger, Knut Liestol, Helle Toldbod, Andrew L. Feldman, Francesco Annibale d'Amore
Publikováno v:
Relander, T, Pedersen, M B, Ellin, F, Lauritzsen, G F, Jantunen, E, Hagberg, H, Holte, H, Österborg, A, Nully Brown, P D, Kuittinen, O, Erlanson, M, Østenstad, B, Fagerli, U-M, Delabie, J, Sundström, C, Sander, B, Hamilton-Dutoit, S J, Ehinger, M, Liestøl, K, Toldbod, H E, Feldman, A L & d'Amore, F A 2022, ' Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial ', Blood, vol. 140, no. Supplement 1, pp. 1479–1480 . https://doi.org/10.1182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7cbbd991c1c85a79970c806f13128bc
https://pure.au.dk/portal/da/publications/longterm-followup-of-clinical-outcome-determinants-and-correlative-biological-features-from-the-nordic-nlgt01-trial(fad79399-b8e2-47f1-b89e-3d77bc095bda).html
https://pure.au.dk/portal/da/publications/longterm-followup-of-clinical-outcome-determinants-and-correlative-biological-features-from-the-nordic-nlgt01-trial(fad79399-b8e2-47f1-b89e-3d77bc095bda).html
Autor:
Knud Bendix, Gabriel A. Rabinovich, Torben Steiniche, Martin Bjerregård Pedersen, Johanne Marie Holst, Francesco d'Amore, Trine Lindhardt Plesner, Peter Nørgaard, Stephen Hamilton-Dutoit, Maja Ludvigsen, Michael Boe Møller
Publikováno v:
Holst, J M, Ludvigsen, M, Hamilton-Dutoit, S J, Bendix, K, Plesner, T L, Nørgaard, P, Møller, M B, Steiniche, T, Rabinovich, G A, d'Amore, F & Pedersen, M B 2020, ' High intratumoural galectin-1 expression predicts adverse outcome in ALK − ALCL and CD30 + PTCL-NOS ', Hematological Oncology, vol. 38, no. 1, pp. 59-66 . https://doi.org/10.1002/hon.2702
Holst, J M, Ludvigsen, M, Hamilton-Dutoit, S J, Bendix, K, Plesner, T L, Nørgaard, P, Møller, M B, Steiniche, T, Rabinovich, G A, d'Amore, F & Pedersen, M B 2020, ' High intratumoural galectin-1 expression predicts adverse outcome in ALK-ALCL and CD30+ PTCL-NOS ', Hematological Oncology, vol. 38, no. 1, pp. 59-66 . https://doi.org/10.1002/hon.2702
Holst, J M, Ludvigsen, M, Hamilton-Dutoit, S J, Bendix, K, Plesner, T L, Nørgaard, P, Møller, M B, Steiniche, T, Rabinovich, G A, d'Amore, F & Pedersen, M B 2020, ' High intratumoural galectin-1 expression predicts adverse outcome in ALK-ALCL and CD30+ PTCL-NOS ', Hematological Oncology, vol. 38, no. 1, pp. 59-66 . https://doi.org/10.1002/hon.2702
Galectin-1 (Gal-1) has been associated with adverse prognosis in several cancers including lymphoma entities with CD30 expression. However, Gal-1 expression has not been systematically assessed in peripheral T-cell lymphomas (PTCL). Specimens from 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56f5e786286e583d143b666280a9c84a
https://findresearcher.sdu.dk:8443/ws/files/168672413/High_intratumoral_Galectin_1_expression_predicts_adverse_outcome_in_ALK_ALCL_and_CD30_PTCL_NOS.pdf
https://findresearcher.sdu.dk:8443/ws/files/168672413/High_intratumoral_Galectin_1_expression_predicts_adverse_outcome_in_ALK_ALCL_and_CD30_PTCL_NOS.pdf
Autor:
Knud Bendix, Tim Svenstrup Poulsen, Bent Honoré, Søren Besenbacher, Martin Bjerregård Pedersen, Stephen Hamilton-Dutoit, Francesco d'Amore, Kristina Lystlund Lauridsen, Michael Boe Møller, Maja Ludvigsen, Peter Nørgaard
Publikováno v:
Ludvigsen, M, Bjerregård Pedersen, M, Lystlund Lauridsen, K, Svenstrup Poulsen, T, Hamilton-Dutoit, S J, Besenbacher, S, Bendix, K, Møller, M B, Nørgaard, P, d'Amore, F & Honoré, B 2018, ' Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified ', Blood Advances, vol. 2, no. 19, pp. 2533-2542 . https://doi.org/10.1182/bloodadvances.2018019893
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) constitutes a heterogeneous category of lymphomas, which do not fit into any of the specifically defined T-cell lymphoma entities. Both the pathogenesis and tumor biology in PTCL-NOS are
Autor:
Stephen Hamilton-Dutoit, Francesco d'Amore, N. Nora Bennani, Torben Steiniche, Rebecca L. Boddicker, Martin Bjerregård Pedersen, Christopher A. Sattler, Michael Boe Møller, Peter Nørgaard, Andrew L. Feldman, Rhett P. Ketterling, Patrick P. Bedroske, Ivy Luoma, Knud Bendix
Publikováno v:
Pedersen, M B, Hamilton-Dutoit, S J, Bendix, K, Ketterling, R P, Bedroske, P P, Luoma, I M, Sattler, C A, Boddicker, R L, Bennani, N N, Nørgaard, P, Møller, M B, Steiniche, T, d'Amore, F & Feldman, A L 2017, ' DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma : a Danish cohort study ', Blood, vol. 130, no. 4, pp. 554-557 . https://doi.org/10.1182/blood-2016-12-755496
To the editor: Peripheral T-cell lymphomas (PTCLs) represent a group of rare hematological cancers of mature T-cell or natural killer cell origin accounting for 10% to 15% of all lymphomas.[1][1] Although many patients have poor outcomes, some achiev
Autor:
Tayla Heavican, Javeed Iqbal, Andreas Rosenwald, Kai Fu, Julie M. Vose, Laurence de Leval, Sylvia Hartmann, Bhavana J. Dave, Choon Kiat Ong, Yuping Li, Koichi Ohshima, Corinne Haioun, Masao Seto, Ryan A. Wilcox, Edoardo Missiaglia, Timothy W. McKeithan, Waseem Gul Lone, Giorgio Inghirami, Maria Antonella Laginestra, Alyssa Bouska, Philippe Gaulard, Randy D. Gascoyne, Elaine S. Jaffe, Jadd M. Stevens, Jiayu Yu, Bin Tean Teh, Francesco d'Amore, Francesco Bertoni, German Ott, François Lemonnier, Wing C. Chan, Soon Thye Lim, Weiwei Zhang, Cynthia M. Lachel, Elias Campo, Qiang Gong, Rita M. Braziel, Noriaki Yoshida, Timothy Greiner, Maarja-Liisa Nairismagi, Martin Bjerregård Pedersen, Louis M. Staudt, Stefano Pileri, Lisa M. Rimsza, Dennis D. Weisenburger, Chao Wang, Catalina Amador
Publikováno v:
Heavican, T B, Bouska, A, Yu, J, Lone, W G, Amador, C, Gong, Q, Zhang, W, Li, Y, Dave, B J, Nairismägi, M-L, Greiner, T C, Vose, J, Weisenburger, D D, Lachel, C, Wang, C, Fu, K, Stevens, J, Lim, S T, Ong, C K, Gascoyne, R D, Missiaglia, E, Lemonnier, F, Haioun, C, Hartmann, S, Pedersen, M B, Laginestra, MA, Wilcox, R, The, BT, Yoshida, N, Ohshima, K, Seto, M, Rosenwald, A, Ott, G, Campo, E, Rimsza, L M, Jaffe, E S, Braziel, R M, d'Amore, F A, Inghirami, G, Bertoni, F, de Leval, L, Gaulard, P, Staudt, L M, McKeithan, T W, Pileri, S A, Chan, W C & Iqbal, J 2019, ' Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma ', Blood, vol. 133, no. 15, pp. 1664-1676 . https://doi.org/10.1182/blood-2018-09-872549
Peripheral T-cell lymphoma (PTCL) is a group of complex clinicopathological entities, often associated with an aggressive clinical course. Angioimmunoblastic T-cell lymphoma (AITL) and PTCL-not otherwise specified (PTCL-NOS) are the 2 most frequent c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1816540e6e9dd40de5b60405b672d6
https://pure.au.dk/portal/da/publications/genetic-drivers-of-oncogenic-pathways-in-molecular-subgroups-of-peripheral-tcell-lymphoma(c36deca9-bc03-44ba-87a4-eeb61498c32d).html
https://pure.au.dk/portal/da/publications/genetic-drivers-of-oncogenic-pathways-in-molecular-subgroups-of-peripheral-tcell-lymphoma(c36deca9-bc03-44ba-87a4-eeb61498c32d).html
Autor:
Waseem Gul Lone, Lynette M. Smith, Karen Tatiana Galvis, Anja Mottok, Catalina Amador, Julie M. Vose, Claudio Agostinelli, Alyssa Bouska, German Ott, Soon Thye Lim, Timothy C. Greiner, Elaine S. Jaffe, Lisa M. Rimsza, Francesco d'Amore, Martin Bjerregård Pedersen, Wing C. Chan, Louis M. Staudt, Stefano Pileri, Andrew L. Feldman, Andreas Rosenwald, Kerry J. Savage, Choon Kiat Ong, Sarah L. Ondrejka, Dennis D. Weisenburger, Laurence de Leval, Philippe Gaulard, Tayla Heavican, Joo Y. Song, Javeed Iqbal, Elias Campo
Publikováno v:
Amador, C, Greiner, T C, Heavican, T B, Smith, L M, Galvis, K T, Lone, W G, Bouska, A, D'amore, F, Bjerregård Pedersen, M, Pileri, S A, Agostinelli, C, Feldman, A L, Rosenwald, A, Ott, G, Mottok, A, Savage, K J, de Leval, L, Gaulard, P, Lim, S T, Ong, C K, Ondrejka, S L, Song, J, Campo, E, Jaffe, E S, Staudt, L M, Rimsza, L M, Vose, J, Weisenburger, D D, Chan, W C, Iqbal, J & Lymphoma/Leukemia Molecular Profiling Project 2019, ' Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry ', Blood, vol. 134, no. 24, pp. 2159-2170 . https://doi.org/10.1182/blood.2019000779
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of mature T-cell malignancies with approximately one-third of cases designated as PTCL-not otherwise specified (PTCL-NOS). Using gene expression profiling (GEP), we have previously defined tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586dd2c64ffbec38f513cdf85a971808
http://hdl.handle.net/11585/725163
http://hdl.handle.net/11585/725163
Autor:
Rebecca A, Luchtel, Surendra, Dasari, Naoki, Oishi, Martin Bjerregård, Pedersen, Guangzhen, Hu, Karen L, Rech, Rhett P, Ketterling, Jagmohan, Sidhu, Xueju, Wang, Ryohei, Katoh, Ahmet, Dogan, N Sertac, Kip, Julie M, Cunningham, Zhifu, Sun, Saurabh, Baheti, Julie C, Porcher, Jonathan W, Said, Liuyan, Jiang, Stephen Jacques, Hamilton-Dutoit, Michael Boe, Møller, Peter, Nørgaard, N Nora, Bennani, Wee-Joo, Chng, Gaofeng, Huang, Brian K, Link, Fabio, Facchetti, James R, Cerhan, Francesco, d'Amore, Stephen M, Ansell, Andrew L, Feldman
Publikováno v:
Blood. 132(13)
Anaplastic large cell lymphomas (ALCLs) are CD30-positive T-cell non-Hodgkin lymphomas broadly segregated into ALK-positive and ALK-negative types. Although ALK-positive ALCLs consistently bear rearrangements of the ALK tyrosine kinase gene, ALK-nega
Autor:
Francesco d'Amore, Xueju Wang, Brian K. Link, Ryohei Katoh, Surendra Dasari, Wee Joo Chng, Andrew L. Feldman, Ahmet Dogan, Stephen Hamilton-Dutoit, Stephen M. Ansell, Saurabh Baheti, Gaofeng Huang, Rebecca A. Luchtel, N. Nora Bennani, Peter Nørgaard, Rhett P. Ketterling, Michael Boe Møller, Julie M. Cunningham, James R. Cerhan, Julie C. Porcher, Naoki Oishi, N. Sertac Kip, Fabio Facchetti, Martin Bjerregård Pedersen, Jonathan W. Said, Jagmohan S. Sidhu, Zhifu Sun, Guangzhen Hu, Liuyan Jiang, Karen L. Rech
Publikováno v:
Luchtel, R A, Dasari, S, Oishi, N, Pedersen, M B, Hu, G, Rech, K L, Ketterling, R P, Sidhu, J, Wang, X, Katoh, R, Dogan, A, Kip, N S, Cunningham, J M, Sun, Z, Baheti, S, Porcher, J C, Said, J W, Jiang, L, Hamilton-Dutoit, S J, Møller, M B, Nørgaard, P, Bennani, N N, Chng, W J, Huang, G, Link, B K, Facchetti, F, Cerhan, J R, D’Amore, F, Ansell, S M & Feldman, A L 2018, ' Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements ', Blood, vol. 132, no. 13, pp. 1386-1398 . https://doi.org/10.1182/blood-2018-03-838524
Luchtel, R A, Dasari, S, Oishi, N, Pedersen, M B, Hu, G, Rech, K L, Ketterling, R P, Sidhu, J, Wang, X, Katoh, R, Dogan, A, Kip, N S, Cunningham, J M, Sun, Z, Baheti, S, Porcher, J C, Said, J W, Jiang, L, Hamilton-Dutoit, S J, Møller, M B, Nørgaard, P, Bennani, N N, Chng, W-J, Huang, G, Link, B K, Facchetti, F, Cerhan, J R, d'Amore, F, Ansell, S M & Feldman, A L 2018, ' Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements ', Blood, vol. 132, no. 13, pp. 1386-1398 . https://doi.org/10.1182/blood-2018-03-838524
Luchtel, R A, Dasari, S, Oishi, N, Pedersen, M B, Hu, G, Rech, K L, Ketterling, R P, Sidhu, J, Wang, X, Katoh, R, Dogan, A, Kip, N S, Cunningham, J M, Sun, Z, Baheti, S, Porcher, J C, Said, J W, Jiang, L, Hamilton-Dutoit, S J, Møller, M B, Nørgaard, P, Bennani, N N, Chng, W-J, Huang, G, Link, B K, Facchetti, F, Cerhan, J R, d'Amore, F, Ansell, S M & Feldman, A L 2018, ' Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements ', Blood, vol. 132, no. 13, pp. 1386-1398 . https://doi.org/10.1182/blood-2018-03-838524
Anaplastic large cell lymphomas (ALCLs) are CD30-positive T-cell non-Hodgkin lymphomas broadly segregated into ALK-positive and ALK-negative types. Although ALK-positive ALCLs consistently bear rearrangements of the ALK tyrosine kinase gene, ALK-nega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3381627f2a51382d3bb0869187b71e5
http://hdl.handle.net/11379/510742
http://hdl.handle.net/11379/510742
Autor:
Lars C. Gormsen, Anne Ortved Gang, Karen Juul Mylam, Martin Bjerregård Pedersen, Jakob Madsen, Victor Vishwanath Iyer, Helle Westergreen Hendel, Peter de Nully Brown, Anne Lerberg Nielsen, Tarec Christoffer El-Galaly, Martin Hutchings, Martin Bøgsted, Annika Loft
Publikováno v:
American Journal of Hematology. 90:975-980
According to the updated guidelines for imaging in lymphoma, 18F-FDG positron emission tomography/computed tomography (PET/CT) is recommended for staging and evaluation of treatment response in FDG-avid lymphomas. The purpose of the study was to eval
Autor:
Andrea Bacigalupo, Kerry Atkinson, Hillard M. Lazarus, Armand Keating, Reinhold Munker, Thomas Relander, Grete F. Lauritzsen, Martin Bjerregård Pedersen, Helle Toldbod, Esa Jantunen, Susanna Mannisto, Fredrik Ellin, Syed Ali Abutalib, Peter Meyer, Robert Peter Gale, Francesco d'Amore
Publikováno v:
Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::068321b63019af8e31272de5ec72de6b
https://doi.org/10.1017/9781316335727.045
https://doi.org/10.1017/9781316335727.045